Article Versions Notes

Zaib T, Cheng K, Liu T, Mei R, Liu Q, Zhou X, He L, Rashid H, Xie Q, Khan H, et al. Expression of CD22 in Triple-Negative Breast Cancer: A Novel Prognostic Biomarker and Potential Target for CAR Therapy. International Journal of Molecular Sciences. 2023; 24(3):2152. https://doi.org/10.3390/ijms24032152

Zaib, Tahir, Ke Cheng, Tingdang Liu, Ruyi Mei, Qin Liu, Xiaoling Zhou, Lifang He, Hibba Rashid, Qingdong Xie, Hanif Khan, and et al. 2023. "Expression of CD22 in Triple-Negative Breast Cancer: A Novel Prognostic Biomarker and Potential Target for CAR Therapy" International Journal of Molecular Sciences 24, no. 3: 2152. https://doi.org/10.3390/ijms24032152

Zaib, T., Cheng, K., Liu, T., Mei, R., Liu, Q., Zhou, X., He, L., Rashid, H., Xie, Q., Khan, H., Xu, Y., Sun, P., & Wu, J. (2023). Expression of CD22 in Triple-Negative Breast Cancer: A Novel Prognostic Biomarker and Potential Target for CAR Therapy. International Journal of Molecular Sciences, 24(3), 2152. https://doi.org/10.3390/ijms24032152